Formulation and in-vitro characterization of retinoic acid loaded poly (lactic-co-glycolic acid) microspheres

References

• Achkar CC, Bentel JM, Boylan JF, Scher HI, Gudas LJ, Miller WH. Differences in the pharmacokinetic properties of orally administered all-trans-retinoic acid and 9-cis-retinoic acid in the plasma of nue mice. Drug Metabolism Disposition 1994; 22: 451–458
   PubMed Web of Science ®Google Scholar
• Barichello JM, Morishita M, Takayama K, Nagai T. Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method. Drug Developments in Industrial Pharmaceutics 1999; 25: 471–476
   PubMed Web of Science ®Google Scholar
• Benita S, Benoit JP, Puisieux F, Thies C. Characterisation of drug loaded poly(DL-lactide) microspheres. Journal of Pharmaceutical Science 1984; 79: 1721–1724
   Web of Science ®Google Scholar
• Bodmeier R, McGinity JW. Solvent selection in the preparation of poly(DL-lactide) microspheres prepared by the solvent evaporation method. International Journal of Pharmaceutics 1988; 43: 179–186
   Web of Science ®Google Scholar
• Castaigne S, Chomienne C, Daniel MT, Fenaux P, Berger R, Degos L. All-trans retinoic acid as a differentiation therapy in acute promyelocytic leukemias. I. Clinical results. Blood 1990; 76: 1704–1710
   PubMed Web of Science ®Google Scholar
• Cavalier M, Benoit JP, Thies C. The formation and characterization of hydrocortisone loaded poly(D-L-lactice) microspheres. Journal of Pharmaceutics & Pharmacology 1986; 38: 249–253
   PubMed Web of Science ®Google Scholar
• Chan Lee S, Oh JT, Jang MH, Chung S. Quantitative analysis of polyvinyl alcohol on the surface of poly(D-L-lactide-co-glycolide) microparticles prepared by solvent evaporation method: Effect of particle size and PVA concentration. Journal of Controlled Release 1999; 59: 123–132
   PubMed Web of Science ®Google Scholar
• Choi Y, Kim SY, Kim SH, Lee KS, Kim C, Byun Y. Long-term delivery of all-trans-retinoic acid using biodegradable PLLA/PEG-PLLA blended microspheres. International Journal of Pharmaceutics 2001; 215: 67–81
   PubMed Web of Science ®Google Scholar
• Conti B, Genta T, Modena F, Pavenotti F. Investigation on process parameters involved in PLGA microspheres preparation. Drug Developments in Industrial Pharmaceutics 1995; 21: 615–622
   Web of Science ®Google Scholar
• Defer GI, Adle-Biassette H, Ricolfi F, Martin L, Authier FJ, Chomienne C, Degos JD. All-trans retinoic acid in relapsing malignant gliomas: Clinical and radiological stabilization associated with the appearance of intratumoral calcifications. Journal of Neurooncology 1997; 34: 169–177
   PubMed Web of Science ®Google Scholar
• Delva L, Cornic M, Balitrand M, Chomienne C. Application therapeutique de l'acide retinoique dans la leucemie aique promyelocytaire. Immunoanalytical Biology Species 1991; 25: 17–21
   Google Scholar
• Doyle JW, Dowgiert RK, Buznet SM. Factor modulating the effect of retinoids on cultured retinal pigment epithelial cell proliferation. Current Eye Research 1992; 11: 753–765
   PubMed Web of Science ®Google Scholar
• Ezpelata I, Irache JM, Stainmesse S, Chabenat C, Gueguen J, Popineau Y, Orecchioni AM. Gliadin nanoparticles for the controlled release of all-trans-retinoic acid. International Journal of Pharmaceutics 1996; 131: 191–200
   Web of Science ®Google Scholar
• Fong JW, Maulding HV, Visscher GE, Nazareno JP, Pearson JE. Enhancing drug release from poly(lactide) microspheres by using base in the microencapsulation process. Controlled release technology, pharmaceutical applications, P Lee, WR Good. American Chemical Society, Washington DC 1987
   Google Scholar
• Frankel SR, Eardley A, Lauwers G, Weiss M, Warrell RP. The ‘retinoic acid syndrome’ in acute promyelocytic leukemia. Annals of Internal Medicine 1992; 117: 292–296
   PubMed Web of Science ®Google Scholar
• Giannini F, Maestro R, Vukosa T, Vljevic T, Pomponi F, Boiocchi M. All-trans, 13-cis and 9-cis retinoic acids induce a fully reversible growth inhibition in HNSCC cell lines: Implications for in vivo retinoic acid use. International Journal of Cancer 1997; 70: 194–200
   PubMed Web of Science ®Google Scholar
• Giordano GG, Refojo MF, Arroyo MH. Sustained delivery of retinoic acid from microspheres of biodegradable polymer in PVR. Invest. Ophthalmology & Vision Science 1993; 34: 2743–2751
   PubMed Web of Science ®Google Scholar
• Hagan SA, Coombes AGA, Garnett MC, Dunn SE, Davies MC, Illum L, Davis SS. Polylactide-poly(ethylene glycol) copolymers as drug delivery systems. I. Characterization of water dispersible micelle-forming systems. Langmuir 1996; 12: 2153
   Web of Science ®Google Scholar
• Herero-Vanrell R, Refojo MF. Biodegradable microspheres for vitreoretinal drug delivery. Advanced Drug Delivery Reviews 2001; 52: 5–16
   PubMed Web of Science ®Google Scholar
• Huang ME, Ye YC, Chen SR. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 1988; 72: 567–571
   PubMed Web of Science ®Google Scholar
• Ike O, Shimizu Y, Wada R, Hyon SH, Ikada Y. Controlled cisplatin delivery system using poly(DL-lactic acid). Biomaterials 1992; 13: 230–234
   PubMed Web of Science ®Google Scholar
• Izumikawa S, Yoshioka S, Aso Y, Takeda Y. Preparation of poly(L-lactide) microspheres of different crystalline morphology and effect of crystalline morphology on drug release rate. Journal of Controlled Release 1991; 15: 133–140
   Web of Science ®Google Scholar
• Jalil R, Nixon JR. Microencapsulation using poly(DL-lactic acid). III. Effect of polymer molecular weight on the release kinetics. Journal of Microencapsulation 1990; 7: 357–374
   PubMed Web of Science ®Google Scholar
• Jeon HJ, Jeong Y, Jang MK, Park YH, Nah JW. Effect of solvent on the preparation of surfactant free poly(DL-lactide-co-glycolide) nanoparticles and norfloxacin release characteristics. International Journal of Pharmaceutics 2000; 207: 99–108
   PubMed Web of Science ®Google Scholar
• Jeong Y II, Song JG, Kang SS, Ryu HH, Lee YH, Choi C, Shin BA, Kim KK, Ahn KY, Jung S. Preparation of poly(DL-lactide-co-glycolide) microspheres encapsulating all-trans retinoic acid. International Journal of Pharmaceutics 2003; 259: 79–91
   PubMed Web of Science ®Google Scholar
• Kompella UB, Bandi N, Ayalasomayajula SP. Subconjuctival nano and microparticles sustain retinal delivery of budesonide, a corticosteroid capable of inhibiting VEGF expression. Investigations in Ophthalmology & Vision Science 2003; 44: 1192–1201
   PubMed Web of Science ®Google Scholar
• Kruptiza G, Hulla W, Harant H, Dittrich E, Kallay E, Huber H. Retinoic acid induced death of ovarian carcinoma cells with c-myc stimulation. International Journal of Cancer 1995; 61: 649–657
   PubMed Web of Science ®Google Scholar
• Lewin AH, Bos ME, Zusi FC, Nair X, Whiting G, Bouquin P, Tetrault G, Carrol FI. Evaluation of retinoids as therapeutic agents in dermatology. Pharmaceutical Research 1994; 11: 192–200
   PubMed Web of Science ®Google Scholar
• Li A, Zhu X, Brown B, Craft CM. Gene expression networks underlying retinoic acid-induced differentiation of human retinoblastoma cells. Investigations in Ophthalmology & Vision Science 2003; 44: 996–1007
   PubMed Web of Science ®Google Scholar
• Lucero MJ, Vigo J, Leon MJ. Stability of hydrophilic gels of tretinoin. International Journal of Pharmaceutics 1994; 110: 241–248
   Web of Science ®Google Scholar
• Mangelsdorf DJ, Umesono K, Evans RM. The retinoid receptors. Sporn The retinoids: biology, chemistry and medicine, MB Roberts, DS Goodman. Raven Press, New York 1994; 319–349
   Google Scholar
• Masini V, Bonte F, Meybeck A, Wepierre J. Cutaneous bioavailability in hairless rats of tretinoin in liposomes or gels. Journal of Pharmaceutical Sciences 1993; 82: 17–21
   PubMed Web of Science ®Google Scholar
• Mehta AC, Calvert RT. Stability of retinoic acid eye drops. Pharmaceutical Journal 1987; 14: 214–215
   Google Scholar
• Mehta K, Sadeghi T, McQueen T, Lopez-Berestein G. Liposome encapsulation circumvents the hepatic clearance mechanisms of all-trans-retinoic acid. Leukemia Research 1994; 18: 587–596
   PubMed Web of Science ®Google Scholar
• Menei P, Daniel V, Montero-Menei C, Brouillard M, Pouplard-Barthelaix A, Benoit JP. Biodegradation and brain tissue reaction to poly(DL-lactide-co-glycolide) microspheres. Biomaterials 1993; 14: 470–478
   PubMed Web of Science ®Google Scholar
• Merodio M, Irache JM, Valamanesh F, Mirshabi M. Ocular disposition and tolerance of ganciclovir loaded albumin nanoparticles after intravitreal injection in rats. Biomaterials 2002; 23: 1587–1594
   PubMed Web of Science ®Google Scholar
• Morris-Kay G. Retinoids in normal development and teratogenesis. Science Publications, Oxford 1992
   Google Scholar
• Muindi J, Frankel SR, Miller WH, Jakubowski A, Scheinberg DA, Young CW, Domitrovski E, Warrel Jr RP. Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: Implications for relapse and retinoids ‘resistance’ in patients with acute promyelocytic leukemia. Blood 1992; 79: 299–303
   PubMed Web of Science ®Google Scholar
• Murakami H, Kobayashi M, Takeuchi H, Kawashima Y. Preparation of poly(DL-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method. International Journal of Pharmaceutics 1999; 187: 143–152
   PubMed Web of Science ®Google Scholar
• Parthasaraty R, Gilbert B, Mehta K. Aerosol delivery of liposomal all-trans-retinoic acid to the lungs. Cancer Chemotherapy & Pharmacology 1999; 43: 277–283
   PubMed Web of Science ®Google Scholar
• Sansdrap P, Möes AJ. Influence of manufacturing parameters on the size characteristics and the release profiles of nifedipine from poly(DL-lactide-co-glycolide) microspheres. International Journal of Pharmaceutics 1993; 98: 157–164
   Web of Science ®Google Scholar
• Selek H, Ünlü N, Orhan M, İrkec M. Evaluation of retinoic acid ophthalmic emulsion in dry eye. European Journal of Ophthalmology 2000; 10: 121–127
   PubMed Web of Science ®Google Scholar
• Takino T, Koishi K, Takakura Y, Hashida M. Long circulating emulsion carrier systems for highly lipophilic drugs. Biology & Pharmaceutics Bulletin 1994; 17: 121–125
   PubMed Web of Science ®Google Scholar
• Tseng SC, Maumenee AE, Stark WJ. Topical retinoid treatment for various dry-eye disorders. Ophthalmology 1985; 92: 717–727
   PubMed Web of Science ®Google Scholar
• Van Bennekum AM, Emei JJ, Kooistra T, Hendriks HFJ. Modulation of tissue type plasminogen activator by retinoids in rat plasma and tissues. American Journal of Physiology 1993; R931: 264
   Google Scholar
• Verstraeten T, Hartzer M, Wilcox DK, Chen M. Effects of vitamin A on retinal pigment epithelial cells in vitro. Investigations in Ophthalmology & Vision Science 1992; 33: 2830–2838
   PubMed Web of Science ®Google Scholar